JP2021510715A5 - - Google Patents
Info
- Publication number
- JP2021510715A5 JP2021510715A5 JP2020539240A JP2020539240A JP2021510715A5 JP 2021510715 A5 JP2021510715 A5 JP 2021510715A5 JP 2020539240 A JP2020539240 A JP 2020539240A JP 2020539240 A JP2020539240 A JP 2020539240A JP 2021510715 A5 JP2021510715 A5 JP 2021510715A5
- Authority
- JP
- Japan
- Prior art keywords
- iron
- artemisinin
- use according
- leukemia
- arsenic trioxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1800736.9A GB201800736D0 (en) | 2018-01-17 | 2018-01-17 | Combination therapy for treatment of leukemia |
| GB1800736.9 | 2018-01-17 | ||
| PCT/GB2019/050124 WO2019141988A1 (en) | 2018-01-17 | 2019-01-17 | Combination therapy for treatment of leukemia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021510715A JP2021510715A (ja) | 2021-04-30 |
| JP2021510715A5 true JP2021510715A5 (https=) | 2022-01-24 |
Family
ID=61256143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020539240A Pending JP2021510715A (ja) | 2018-01-17 | 2019-01-17 | 白血病治療のための併用療法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11400112B2 (https=) |
| EP (1) | EP3740215A1 (https=) |
| JP (1) | JP2021510715A (https=) |
| CN (1) | CN111818930A (https=) |
| GB (1) | GB201800736D0 (https=) |
| WO (1) | WO2019141988A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220226372A1 (en) * | 2019-05-21 | 2022-07-21 | Medsenic | Use of metal ions to potentiate the therapeutic effects of arsenic |
| EP3868372A1 (en) * | 2020-02-19 | 2021-08-25 | JLP Health GmbH | A pharmaceutical combination of an artemisinin compound and a heme synthesis modulator for treating cancer |
| US11583552B2 (en) | 2021-02-17 | 2023-02-21 | Manoj Maniar | Pharmaceutical formulation of arsenic trioxide |
| CN116687965A (zh) * | 2023-05-05 | 2023-09-05 | 杭州市西溪医院 | 一种三氧化二砷-青蒿琥酯抗肿瘤组合物、双载药纳米脂质体及其制备方法和用途 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04273819A (ja) * | 1991-02-28 | 1992-09-30 | Takeda Chem Ind Ltd | 血圧上昇剤 |
| CN1044559C (zh) | 1995-08-23 | 1999-08-11 | 哈尔滨医科大学附属第一医院 | 抗白血病、肝癌、淋巴瘤注射液 |
| TR200002243T2 (tr) * | 1997-11-10 | 2000-12-21 | Memorial Sloan-Kettering Cancer Center | Arsenik trioksitin hazırlanması için işlem ve bunların kanser tedavisi için kullanımı. |
| CA2488347A1 (en) * | 2002-06-06 | 2003-12-18 | University Of Washington | Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
| JP2008201765A (ja) * | 2007-01-26 | 2008-09-04 | Jichi Medical Univ | 腫瘍治療における三酸化二ヒ素の副作用低減剤及び解毒剤 |
| CN102614168A (zh) * | 2011-01-31 | 2012-08-01 | 上海交通大学医学院附属瑞金医院 | 一种青蒿素衍生物及其药用盐的应用 |
| CN103202835B (zh) | 2012-01-16 | 2015-05-13 | 上海交通大学医学院附属瑞金医院 | 青蒿素衍生物及其药用盐用于制备治疗急性白血病的药物 |
| CN103202836B (zh) | 2012-01-16 | 2015-05-13 | 上海交通大学医学院附属瑞金医院 | 青蒿素衍生物及其药用盐用于制备治疗急性髓细胞性白血病的药物 |
| CN103202837B (zh) | 2012-01-16 | 2015-05-13 | 上海交通大学医学院附属瑞金医院 | 青蒿素衍生物及其药用盐用于治疗制备白血病的药物 |
| US9801851B2 (en) | 2012-05-23 | 2017-10-31 | St. Jude Children's Research Hospital | Methods and compositions for the treatment of BCR-ABL positive lymphoblastic leukemias |
| CN103845322A (zh) | 2012-11-29 | 2014-06-11 | 昆明制药集团股份有限公司 | 蒿甲醚在制备治疗白血病的药物中的用途 |
| CN103845360A (zh) * | 2012-11-29 | 2014-06-11 | 昆明制药集团股份有限公司 | 含蒿甲醚的药物组合物、制剂及其用途 |
| CN104739824A (zh) | 2013-12-30 | 2015-07-01 | 昆山达人生物医药有限公司 | 双氢青蒿素在制备抑制肿瘤生长药物中的应用 |
| EP3233918A1 (en) * | 2014-12-19 | 2017-10-25 | Novartis AG | Combination therapies |
| US9918972B2 (en) | 2014-12-23 | 2018-03-20 | The University Of Maryland, Baltimore | Treatment of leukemia with artemisinin derivatives and combinations with other antineoplastic agents |
| US10925963B2 (en) | 2015-06-22 | 2021-02-23 | Washington University | Combination artemisinin and chemiluminescent photodynamic therapy and uses therefor |
-
2018
- 2018-01-17 GB GBGB1800736.9A patent/GB201800736D0/en not_active Ceased
-
2019
- 2019-01-17 CN CN201980017188.1A patent/CN111818930A/zh active Pending
- 2019-01-17 JP JP2020539240A patent/JP2021510715A/ja active Pending
- 2019-01-17 US US16/962,494 patent/US11400112B2/en active Active
- 2019-01-17 EP EP19701714.8A patent/EP3740215A1/en active Pending
- 2019-01-17 WO PCT/GB2019/050124 patent/WO2019141988A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021510715A5 (https=) | ||
| JP2023541432A5 (https=) | ||
| JP2023541430A5 (https=) | ||
| JP2006504723A5 (https=) | ||
| JP2014512356A5 (https=) | ||
| JP2024516795A5 (https=) | ||
| JP2024516363A5 (https=) | ||
| JP2010525050A5 (https=) | ||
| JP2010270124A5 (https=) | ||
| JP2013520971A5 (https=) | ||
| JP2005535606A5 (https=) | ||
| JP2011515481A5 (https=) | ||
| JP2020521797A5 (https=) | ||
| JP2012524089A5 (https=) | ||
| JP2013518124A5 (https=) | ||
| JP2005511597A5 (https=) | ||
| WO2013173542A4 (en) | Methods for treating cancer with notch2/3 antibodies | |
| JP2023550149A5 (https=) | ||
| JP2018522028A5 (https=) | ||
| JP2006500346A5 (https=) | ||
| JP2009515901A5 (https=) | ||
| JP2015507020A5 (https=) | ||
| RU2018107930A (ru) | Агонисты tlr4, их композиции и применение для лечения рака | |
| JP2015518053A5 (https=) | ||
| JP2005530735A5 (https=) |